Capability Overview: Lentiviral Vector Manufacturing

Center for Breakthrough Medicines

Reinforcing lentiviral supply through first-time right manufacturing success

Center for Breakthrough Medicines (CBM) is an advanced therapy CDMO dedicated to delivering life-changing treatments to patients that need them. dedicated to delivering life-changing treatments to patients that need them.

Download to the data sheet to learn more about CBM’s Lentivirus capabilities.

Lentivirus (LV) is in short supply and high demand due to being a crucial starting material to ex-vivo gene therapy and in-vivo gene therapy due to persistent gene transfer and the ability to transduce non-proliferating cells.

CBM’s purpose-built, commercial-ready facility is engineered and outfitted to support lentiviral manufacturing with a commitment to 100% batch to support lentiviral manufacturing with a commitment to 100% batch success. Robust segregation, biosafety controls, and drug product success. Robust segregation, biosafety controls, and drug product services ensure near zero drug product loss for the patients that need it.

Download to the data sheet to learn more about CBM’s Lentivirus capabilities.